EP3516060
Tjáningarhindrar til að meðhöndla augnsjúkdóm
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.9.2017EP published:
21.7.2021EP application number:
17781030.6
EP translation filed:
1.9.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
21.9.2037Expiry date:
21.9.2026Next due date:
30.9.2026
Title:
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
Timeline
Today
22.9.2017EP application
21.7.2021EP Publication
1.9.2021Translation submitted
15.9.2021Registration published
21.9.2026Expires
Owner
Name:
Laboratoires THEAAddress:
12, rue Blériot, Z.I. du Brezet, 63100 CLERMONT-FERRAND, FR
Inventor
Name:
VAN DIEPEN, Hester CatharinaAddress:
2333 CK Leiden, NL
Name:
TURUNEN, Janne JuhaAddress:
2333 CK Leiden, NL
Name:
CHAN, Hee LamAddress:
2333 CK Leiden, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201616202Date:
23.9.2016Country:
GB
Classification
Categories:
C12N 15/113, A61K 31/7088, A61K 31/712, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 30.9.2021
Expires: 21.9.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 31.8.2022
Expires: 21.9.2023
Payer: Patice ehf.
Number: 7
Paid: 19.9.2023
Expires: 21.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.8.2024
Expires: 21.9.2025
Payer: Acumass
Number: 9
Paid: 20.8.2025
Expires: 21.9.2026
Payer: Acumass